AbbVie (ABBV) Declares $0.51 Quarterly Dividend; 3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Receptos (RCPT) Will Be Patient on Takeover, Leerink Partners Says; Insider Sales Not a Tell
June 17, 2015 5:04 PM EDTIn a report on Receptos (NASDAQ: RCPT) after the close, Leerink Partners analyst Joseph Schwartz noted weakness in the stock today followed a blog post which highlighted the Form 4 filed by LLY Ventures Partner last evening (6/16) disclosing sale of ~20% stake (equivalent of ~$40MM), which he said could be indirectly viewed as management lack of willingness for a potential deal in the near future. Schwartz does not share this view and continues to believe that mgmt. is... More
UPDATE: Piper Jaffray Starts Abbvie (ABBV) at Overweight
June 16, 2015 4:36 PM EDT(Updated - June 17, 2015 7:54 AM EDT)
Piper Jaffray initiated coverage on Abbvie (NYSE: ABBV) with an Overweight rating and a price target of $77.00.
Analyst Richard Purkiss commented, "we see AbbVie as a highly defensive near-term growth story with a differentiated dividend outlook. Near-term... More
